Related news and resources
Considerations on the use of reliance in clinical trials review
The global clinical trial landscape is undergoing a profound transformation, driven by the increasing use of multiregional clinical trial designs, rapid advances in science and technology, and the growing need for coordinated regulatory approaches. With the expansion of multiregional clinical research, the need for harmonized regulatory frameworks has become more urgent. Despite this shift, regulatory...
Read more
WIPO Committee on IP and Development (CDIP 35): Technology Transfer
On 20 November 2025, IFPMA submitted a statement on technology transfer at the WIPO Committee on IP and Development (CDIP 35) in Geneva. Technology transfer in the pharmaceutical sector is a complex and resource-intensive process. It requires significant technical expertise, time, and investment, as well as a robust, stable, and predictable intellectual property framework, which...
Read moreBiopharmaceutical CEOs Roundtable met in Berlin
12 NOVEMBER 2025, Berlin – The Biopharmaceutical CEOs Roundtable (BCR), a global policy platform representing the world’s leading biopharmaceutical companies, convened last week in Berlin to discuss how pharmaceutical innovation can drive better health outcomes, strengthen economies, and enhance global health security. The BCR delegation also met with Federal Chancellor Merz, along with key members...
Read more